Unlicensed medicines use: a UK guideline analysis using AGREE II.

Gemma DonovanLindsay ParkinLyn Brierley-JonesScott Wilkes

Published in: The International journal of pharmacy practice (2018)

Healthcare organisations would benefit from agreeing a 'core content' for the development of unlicensed medicines guidelines to ensure consistency and the presence of robust operating systems to deliver safe, effective treatment to all NHS patients.

Keyphrases

healthcare
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient safety
cross sectional
patient reported outcomes
combination therapy